Comparison of anti-cancer effects of novel protein disulphide isomerase (PDI) inhibitors in breast cancer cells characterized by high and low PDIA17 expression

Abstract Background Protein disulphide isomerases (PDIs) play an important role in cancer progression. However, the relative contribution of the various isoforms of PDI in tumorigenesis is not clear. Methods The content of PDI isoforms in 22 cancer cells lines was investigated using LC–MS/MS-based p...

Descripció completa

Dades bibliogràfiques

Autors principals:	Anna Kurpińska, Joanna Suraj-Prażmowska, Marta Stojak, Joanna Jarosz, Łukasz Mateuszuk, Ewa Niedzielska-Andres, Magdalena Smolik, Joanna Wietrzyk, Ivars Kalvins, Maria Walczak, Stefan Chłopicki
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2022-06-01
Col·lecció:	Cancer Cell International
Matèries:	Protein disulphide isomerases Anterior gradient 2 (AGR2, PDIA17) Novel PDI inhibitors Endoplasmic reticulum (ER)–resident protein 57 (ERP57, PDIA3) Protein disulphide isomerase A1 (prolyl 4-hydroxylase subunit beta P4HB, PDIA1)
Accés en línia:	https://doi.org/10.1186/s12935-022-02631-w
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!